Krystal Biotech (KRYS) Share-based Compensation (2016 - 2026)
Krystal Biotech (KRYS) posted Share-based Compensation of $13.94 million for Q3 2026, up 6.0% from $13.15 million a year earlier but down 1.5% from the prior quarter.
Powered by 
Analysis
Krystal Biotech (KRYS) Share-based Compensation (2016 - 2026) Analysis & Trends
For the trailing twelve months through Sep 30, 2026, Share-based Compensation at Krystal Biotech was $55.47 million, up 2.5% year-over-year; for FY2025, it came in at $54.51 million, up 11.0% from FY2024.
- Annual Share-based Compensation has increased for nine consecutive years, with a five-year compound annual growth rate of 75.5% (FY2020 to FY2025).
- In prior years, Krystal Biotech's Share-based Compensation was $49.13 million in FY2024 (+23.0%), $39.93 million in FY2023 (+20.2%), $33.23 million in FY2022 (+116.9%) and $15.32 million in FY2021 (+368.2%).
- Quarterly Share-based Compensation has run from a low of $5.15 million in Q4 2021 to a high of $14.16 million in Q2 2026 over five years.
- On a year-over-year basis, Share-based Compensation has increased in each of the last four quarters, with growth averaging 12.1% over the last eight quarters.
- The strongest year-over-year quarter for Share-based Compensation in the past five years was Q4 2021, with growth of 802.6%; the weakest was Q1 2024, with a decline of 10.9%.
- According to Business Quant data, Share-based Compensation for the three prior quarters was $14.16 million (Q2 2026), $13.61 million (Q1 2026) and $13.76 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 200.00 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 357.00 Mn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 160.00 Mn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 369.00 Mn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 128.00 Mn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 234.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 362.00 Mn |
| 10 | Krystal Biotech | 9.08 Bn | 5.67 Bn | 119.79 Mn | 13.94 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 13.94 Mn |
| Jun 30, 2026 | 14.16 Mn |
| Mar 31, 2026 | 13.61 Mn |
| Dec 31, 2025 | 13.76 Mn |
| Sep 30, 2025 | 13.15 Mn |
| Jun 30, 2025 | 14.12 Mn |
| Mar 31, 2025 | 13.48 Mn |
| Dec 31, 2024 | 13.36 Mn |
| Sep 30, 2024 | 13.32 Mn |
| Jun 30, 2024 | 13.16 Mn |
| Mar 31, 2024 | 9.30 Mn |
| Dec 31, 2023 | 9.85 Mn |
| Sep 30, 2023 | 8.31 Mn |
| Jun 30, 2023 | 11.33 Mn |
| Mar 31, 2023 | 10.44 Mn |
| Dec 31, 2022 | 9.55 Mn |
| Sep 30, 2022 | 9.06 Mn |
| Jun 30, 2022 | 8.19 Mn |
| Mar 31, 2022 | 6.43 Mn |
| Dec 31, 2021 | 5.15 Mn |
API Access
Krystal Biotech Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=KRYS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "KRYS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=KRYS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();